Journal Article Summary
The article investigates the feasibility and safety of allowing patients to be discharged on the first postoperative day (PPOD1) after undergoing laparotomy for gynecologic oncology, using a modified enhanced recovery after surgery (ERAS) protocol that includes opioid-sparing anesthesia. This topic is significant as traditional recovery protocols often result in longer hospital stays, which can increase the risk of complications and healthcare costs. By exploring early discharge, the study aims to improve patient outcomes and optimize recovery processes in gynecologic surgery.
In this prospective observational study, 160 patients scheduled for laparotomy or minimally invasive surgery (MIS) were enrolled, with 141 completing the necessary quality of life surveys. The study found that 84.7% of the laparotomy patients had gynecologic malignancies, and the results indicated that PPOD1 was a safe option, as it did not lead to increased opioid use or higher readmission rates compared to the MIS group. Additionally, patient-reported outcomes regarding constipation and nausea/vomiting remained stable, suggesting that the modified ERAS protocol effectively supported recovery.
However, the study has limitations, including its non-randomized design and a lack of a control group that did not use opioid-sparing anesthesia. These factors may affect the interpretation of the results, particularly regarding differences in quality of life between the surgical cohorts. Patients considering this approach should discuss it with their healthcare providers to understand the potential benefits and risks, especially in the context of their specific health conditions and surgical needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Kuznicki Michelle L., Yasukawa Maya, Mallen Adrianne R., Lam Clarissa, Eggers Erica, Regis Jefferson, Wells Ali, Todd Sarah L., et al.. Feasibility and safety of planned early discharge following laparotomy in gynecologic oncology with enhanced recovery protocol including opioid-sparing anesthesia. Frontiers in Surgery 2023. DOI: 10.3389/fsurg.2023.1279907. PMID: 38026485. PMCID: PMC10654978.
Featured Pill Pals Product
Docusate Sodium /Senna 8.6-50 mg Tablets 100 Count --- Generic for Peri-Colace --- Rugby Pharma --- Over The Counter
Docusate Sodium /Senna 8.6-50 mg Tablets 100 Count — Generic for Peri-Colace — Rugby Pharma — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
